Results 191 to 200 of about 119,881 (373)

Pharmacokinetics and Safety of Single‐Dose Apraglutide in Individuals with Normal and Impaired Hepatic Function: A Phase 1, Open‐Label Trial

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Intestinal failure‐associated liver disease occurs in 20% to 30% of patients with short bowel syndrome and intestinal failure (SBS‐IF). Apraglutide is a glucagon‐like peptide‐2 (GLP‐2) analog in clinical development for the treatment of patients with SBS‐IF.
Gerard Greig   +4 more
wiley   +1 more source

TNF-Inhibition With Etanercept For GVHD Prevention In Alternative Donor HCT: Lower TNFR1 Levels Correlate With Better Outcomes [PDF]

open access: hybrid, 2010
Sung Won Choi   +19 more
openalex   +1 more source

Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.

open access: yesBlood, 2016
C. Brunstein   +16 more
semanticscholar   +1 more source

Chronic graft‐versus‐host disease in long‐term survivors of childhood leukemia

open access: yesHemaSphere, Volume 10, Issue 1, January 2026.
Abstract Hematopoietic stem cell transplantation (HSCT) is a curative treatment for high‐risk childhood leukemia but may lead to chronic graft‐versus‐host disease (cGvHD), a severe long‐term complication. This study analyzed data from the LEA cohort, including 446 childhood leukemia survivors treated with allogeneic HSCT.
Paul Saultier   +25 more
wiley   +1 more source

Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning

open access: hybrid, 2010
Frédéric Baron   +11 more
openalex   +1 more source

Eosinophilic Gastrointestinal Disease After Pediatric Organ and Bone Marrow Transplantation

open access: yesJGH Open, Volume 10, Issue 1, January 2026.
ABSTRACT Background Previous studies have shown an increased prevalence of eosinophilic gastrointestinal disease (EGID) in pediatric liver and heart transplant recipients. However, EGID after other solid organ and bone marrow transplantations has not been extensively evaluated.
Erin Sinai   +5 more
wiley   +1 more source

Supplementary Table S3 from Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials

open access: gold, 2023
Eduardo Rodríguez‐Arbolí   +13 more
openalex   +1 more source

Recipient mucosal-associated invariant T cells control GVHD within the colon

open access: yesJournal of Clinical Investigation, 2018
A. Varelias   +21 more
semanticscholar   +1 more source

Cytomegalovirus IL‐10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory Study

open access: yesJournal of Medical Virology, Volume 98, Issue 1, January 2026.
ABSTRACT We investigated whether plasma cytomegalovirus (CMV) IL‐10 (cmvIL‐10) levels could serve as a biomarker of active CMV replication in allogeneic hematopoietic transplant recipients (allo‐HCT) in the presence or absence of letermovir (LMV) prophylaxis. A total of 189 leftover plasma samples that tested positive for CMV DNA (Alinity m CMV assay),
Ángela Sánchez‐Simarro   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy